Ph.D. in Chemical Engineering. "sums up everything that is wrong with the multinational pharmaceutical industry. "I got more and more focused on my studies and decided to study chemistry and get a Ph.D.," he recalls. Bayer is effectively admitting that the drugs they develop are deliberately going to be rationed to the wealthiest patients. Marijn E. Dekkers. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA. He is also the former chairman of Unilever. BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. Dekkers grew up as the youngest of three children of a merchant in the Dutch city of Tilburg. From 2016 to 2019, Dr. Dekkers was Chairman of the board of directors of Unilever. Technische Universiteit Eindhoven . On average, Marijn trades about 2,391 units every 72 days since 2003. Marijn Emmanuel Dekkers (born September 22, 1957 in Tilburg, The Netherlands) is a Dutch-American manager and chemist. The vast majority of education is undergraduate education provided by the departments to students, who are adults with no other academic qualifications than a secondary education diploma. The Company is ISO13485 certified. Quanterix executives and other stock owners filed with the SEC include: "I was not that good a student when I was playing tennis a lot, because I just didn't have the time. During his tenure, Bayer acquired the consumer care business of Merck & Co., Inc., floated the material science subgroup on the stock market under the name “Covestro,” and systematically focused on the life sciences businesses. Advisor Marijn E. Dekkers is founder and chairman of Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry that he founded in 2017. Dr. Marijn E. Dekkers Ph.D. serves as Independent Director of the Company. Dekkers, who remains fit and trim, quickly found another outlet for energy and ambition. in Chemical Engineering from the University of Eindhoven and his B.S. Marijn Dekkers, Ph.D., is a founder and the chairman of Novalis LifeSciences LLC, an investment and advisory firm for the life science industry. Radboud University (abbreviated as RU, Dutch: Radboud Universiteit, formerly Katholieke Universiteit Nijmegen) is a public Roman Catholic university with a strong focus on research located in Nijmegen, the Netherlands.It bears the name of Saint Radboud, the 9th century Dutch bishop who was know for his intellect and support of the underprivileged. He spoke at a conference in 2014, saying"So now, is this going to have a big effect on our business model? This created a global life sciences company which now employs 55,000 people and generates annual sales of $18 billion.Dr. He was CEO of Bayer AG from 2010 to 2016. Dr. Marijn E. Dekkers Ph.D. serves as Independent Director of the Company.
The oldest executive at Quanterix Corp. is Marijn's mailing address filed with the SEC is Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. From 2002-2009, he was CEO of Thermo Fisher Scientific in Waltham, MA, USA. “In 2008, there was not a word about financial crisis; in 2011, no-one mentioned the Arab Spring. Dekkers replied to this, referring to the decision made by the Indian government, not to protect a patent on Nexavar and the intellectual property of Bayer. Marijn Dekkers, Ph.D., is the Founder and Chairman of Novalis LifeSciences LLC, an investment and advisory firm for the life science industry, as well as Chairman of Unilever. "Manager of the Year 2014" by German business magazine "Manager Magazin" "Business person of the Year 2015" by the "Finanzen Verlag" publishing group and the readers of its publications "€uro am Sonntag", "€uro" and "Börse online" "Most Innovative CEO International 2015" by the German industry's "Innovation Award" He also said: I regret that what was a quick response from me within the framework of a panel discussion at the recent FT Pharma conference has come across in a different way as it was meant by myself. After attending local schools, St. Aloysius (primary school) and St. Odulphus (Lyceum), in 1976 he began studying In 2000, he became a director at the Boston-based On 1 January 2010 Dekkers was appointed to the board of Bayer AG and on 1 October 2010 he took over as CEO from Since April 2016 he was the Chairman of In 2017 Dekkers founded Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry (www.novalislifesciences.com). He's CEO of Bayer AG since October 1, 2010. He is also the former Chairman of Unilever. While there he served for two years as President of the German Chemical Industry Association (VCI), Frankfurt.From 2002-2009, Dr. Dekkers served as CEO of Thermo Fisher Scientific (he was COO from 2000-2002). Concurrent, with his advisory role, Dr. Dekkers also made an investment in BioQ Pharma … He was the first Bayer CEO to be appointed from outside the company. “In 2008, there was not a word about financial crisis; in 2011, no-one mentioned the Arab Spring. By using this site, you agree to the By using this site, you agree to the From 2010-2016, Dr. Dekkers served as Bayer AG’s CEO.